Phase 2RecruitingAge-related condition
Efficacy and Safety of BRIMOCHOL PF and CARBACHOL PF in Chinese Presbyopia Patients
A Multicenter, Randomized, Double-Blind, Crossover, Placebo-Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of BRIMOCHOL PF, CARBACHOL PF in Chinese Patients With Presbyopia
- Sponsor
- Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. (Industry)
- Enrollment
- 119 planned
- Conditions
- Presbyopia
- Interventions
- BRIMOCHOL PF eye drops; CARBACHOL PF eye drops; Brimonidine eye drops; Placebo
- Ages
- adults, older adults
- Registry
- NCT06948357
Full record on ClinicalTrials.gov
From the registry
A multicenter, randomized, double-Blind, crossover, placebo-controlled Phase II clinical Study to evaluate the efficacy and safety of BRIMOCHOL PF and CARBACHOL PF in the treatment of Chinese patients with presbyopia.
Primary outcomes
- Changes in MCNVA(monocular corrected near visual acuity) ETDRS letters and MCDVA (monocular corrected distance visual acuity) ETDRS letters from baseline in the study eyes after administration
History
Study completion
Primary completion
Registered
Started